The Highly Anticipated Launch of Promescent Will Take Place at the Annual American Urology Association Conference in Washington, D.C. on May 14th-19th
LOS ANGELES, May 10, 2011 /PRNewswire/ -- A sexy new star, Promescent, will be born this year at the preeminent American Urological Association's Annual Meeting in Washington, D.C. from May 14-19. Already heralded as a miracle maker by over 5,000 regular users and endorsed by America's finest urologists and sex therapists, this FDA monograph, OTC premature ejaculation (PE) spray is a scientific breakthrough that empowers men by eliminating a bedroom dilemma affecting 30% of all males, a problem more prevalent than erectile dysfunction.
"We all know that it takes longer for a woman to reach an orgasm than a man. In fact, the average woman takes 16 minutes to reach an orgasm and an average man takes less than 7 minutes to ejaculate," says world renowned sex therapist, Dr. Felice Dunas. Promescent was developed to increase the quality of life for those suffering from premature ejaculation by boosting self-esteem, improving relationships, and eliminating anxiety."
Promescent, a safe and effective topical spray, has been scientifically formulated to treat the key factor in premature ejaculation, hypersensitivity, and was developed through extensive university research under board certified urologist Dr. Ronald F. Gilbert.
"Premature ejaculation is the most universal form of sexual dysfunction, affecting men of every age. But it is also the least understood. Embarrassment and lack of accurate information prevent many men from seeking medical treatment for premature ejaculation, a condition that not only adversely affects them, but also their partners and relationships," explains Dr. Gilbert. "And many of those who do seek treatment are dissatisfied with the therapies that have been available to date." The most common course of action is the off-label prescription of SSR inhibitors, commonly known as anti-depressants, which are costly, have potentially serious side effects, and must be taken every day to maximize efficacy, not just when needed.
Although a prescription is not required, Promescent offers each patient the unique ability to determine his own optimal dosage. According to Dr. Gilbert, hypersensitivity of the glans ranges on a spectrum, and Promescent is specifically designed to normalize a man's sensitivity, effectively "taking the edge off" and allowing the man to temporarily delay ejaculation and enjoy longer sex. Promescent is formulated to allow each man to personalize his dosage to maximize his sexual experience; the permitted dosage ranges between 3-10 sprays based upon his degree of hypersensitivity.
Promescent is available online at www.promescent.com. Since purchase is easy, discrete, and completely private, G and H Brands expect an enthusiastic response from the millions of men in the U.S. who suffer from premature ejaculation.
A 30-day supply of Promescent is available for $59.95. For more information, visit www.promescent.com.
This press release is being issued by Krupa Consulting.
SOURCE Krupa Consulting